In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Recursion Pharmaceuticals Inc (NASDAQ: RXRX) closed at $8.60 in the last session, up 4.88% from day before closing price of $8.20. In other words, the price has increased by $4.88 from its previous closing price. On the day, 4.94 million shares were traded. RXRX stock price reached its highest trading level at $8.665 during the session, while it also had its lowest trading level at $8.29.
Ratios:
We take a closer look at RXRX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.65 and its Current Ratio is at 4.65. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on May 22, 2023, initiated with a Equal-Weight rating and assigned the stock a target price of $8.
On March 16, 2023, Needham started tracking the stock assigning a Buy rating and target price of $17.
On September 16, 2022, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $20.KeyBanc Capital Markets initiated its Overweight rating on September 16, 2022, with a $20 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 11 ’24 when Gibson Christopher sold 50,000 shares for $7.47 per share. The transaction valued at 373,500 led to the insider holds 758,738 shares of the business.
Gibson Christopher sold 50,000 shares of RXRX for $374,000 on Jul 10 ’24. The Chief Executive Officer now owns 758,738 shares after completing the transaction at $7.48 per share. On Jul 10 ’24, another insider, Secora Michael, who serves as the Chief Financial Officer of the company, sold 15,000 shares for $7.24 each. As a result, the insider received 108,576 and left with 1,316,593 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RXRX now has a Market Capitalization of 2308523776 and an Enterprise Value of 1798562048. For the stock, the TTM Price-to-Sale (P/S) ratio is 49.94 while its Price-to-Book (P/B) ratio in mrq is 5.25. Its current Enterprise Value per Revenue stands at 38.9 whereas that against EBITDA is -5.145.
Stock Price History:
The Beta on a monthly basis for RXRX is 0.84, which has changed by -0.4577554 over the last 52 weeks, in comparison to a change of 0.24125004 over the same period for the S&P500. Over the past 52 weeks, RXRX has reached a high of $16.75, while it has fallen to a 52-week low of $4.97. The 50-Day Moving Average of the stock is -1.21%, while the 200-Day Moving Average is calculated to be -3.20%.
Shares Statistics:
According to the various share statistics, RXRX traded on average about 5.61M shares per day over the past 3-months and 5517240 shares per day over the past 10 days. A total of 226.26M shares are outstanding, with a floating share count of 198.88M. Insiders hold about 25.91% of the company’s shares, while institutions hold 69.42% stake in the company. Shares short for RXRX as of 1719532800 were 44919972 with a Short Ratio of 8.01, compared to 1717113600 on 43637834. Therefore, it implies a Short% of Shares Outstanding of 44919972 and a Short% of Float of 23.84.
